Recent Posts
- Cycle Launches COVID-19 Response For Eligible Patients with Tyrosinemia Type 1 (HT-1)
- Cycle Pharmaceuticals’ NITYR® (nitisinone) Tablets Receives Marketing Authorization in the Kingdom of Saudi Arabia
- Cycle Pharmaceuticals and Medherant Partner to Develop Medicines using the TEPI Patch® Technology
- Cycle Pharmaceuticals Launches New Informative Online Meeting Series for Patients With Tyrosinemia Type 1 in the US
- Cycle Pharmaceuticals’ Supply Chain update
Archives
- No comments have been published yet.
Find us on Facebook
Archives
Recent Posts
- Cycle Launches COVID-19 Response For Eligible Patients with Tyrosinemia Type 1 (HT-1)
- Cycle Pharmaceuticals’ NITYR® (nitisinone) Tablets Receives Marketing Authorization in the Kingdom of Saudi Arabia
- Cycle Pharmaceuticals and Medherant Partner to Develop Medicines using the TEPI Patch® Technology
- Cycle Pharmaceuticals Launches New Informative Online Meeting Series for Patients With Tyrosinemia Type 1 in the US
- Cycle Pharmaceuticals’ Supply Chain update
Recent Tweets
-
Lottie animations! Add a touch of flair to any Avada website with the new Lottie Element. Lightweight & fun, these… twitter.com/i/web/status/1…
21 hours ago -
Make sure that Avada, WordPress, & all plugins are maintained & updated at all times. Schedule regular backups, app… twitter.com/i/web/status/1…
2 days ago -
@jaredlbell Hi Jared, the process has not changed & both plugins are still updated via the plugins section. If you… twitter.com/i/web/status/1…
2 days ago
Recent Comments